ROIVANT SCIENCES LTD (ROIV:NASDAQ)
$35.44 1.23 (3.5954%)
Analysed ROIVANT SCIENCES LTD (ROIV:NASDAQ) News Sources
These 2 Biotech Stocks Hit Record Highs Today – What’s Driving The Rallies?
08-09-2026
stocktwits.com
Roivant (ROIV) Soars to All-Time High; Q2 Hedge Fund Holdings Surge 41%
09-09-2026
yahoo.com
Company News for Sep 9, 2026
09-09-2026
yahoo.com
Roivant Sciences Ltd. (ROIV)’s Pulmonary Hypertension Breakthrough Could Transform Its Growth Story
13-09-2026
yahoo.com
What Is Roivant Sciences (ROIV) Signaling With Its Positive PH ILD Trial Data?
18-09-2026
yahoo.com
Roivant (ROIV): $9 Billion Sales Potential Faces a Commercialization Test
22-09-2026
yahoo.com
Roivant’s Immunovant Stops IMVT-1402 Development in Cutaneous Lupus After Trial Miss
23-09-2026
advfn.com
Roivant’s Lung Drug Clears Phase 2 Test: Is Another Major Pipeline Asset Emerging?
24-09-2026
yahoo.com
Roivant Sciences Targets LISRAYA Launch, Key Pipeline Readouts in Next 12 Months
28-09-2026
marketbeat.com
IMVT, ROIV Stocks Slide As Argenx Sjögren’s Trial Failure Hits Drug Class
08-10-2026
stocktwits.com
What is the current price of ROIVANT SCIENCES LTD (ROIV:NASDAQ)?
The current price of ROIVANT SCIENCES LTD (ROIV:NASDAQ) is $35.44.
ROIVANT SCIENCES LTD (ROIV:NASDAQ) absolute price change since previous trading day?
The absolute price change of ROIVANT SCIENCES LTD (ROIV:NASDAQ) since the previous trading day is $1.23.
ROIVANT SCIENCES LTD (ROIV:NASDAQ) percentage price change since previous trading day?
The percentage price change of ROIVANT SCIENCES LTD (ROIV:NASDAQ) since the previous trading day is 3.5954%.
What is the most recent average sentiment score for ROIVANT SCIENCES LTD (ROIV:NASDAQ)?
The most recent average sentiment score for ROIVANT SCIENCES LTD (ROIV:NASDAQ) is 90 out of 100.
What is the most recent average sentiment for ROIVANT SCIENCES LTD (ROIV:NASDAQ)?
The most recent sentiment for ROIVANT SCIENCES LTD (ROIV:NASDAQ) is .
SEC-8K** Filing Available For ROIVANT SCIENCES LTD (ROIV:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.